Neuphoria Therapeutics Inc. financial data

Symbol
NEUP on Nasdaq
Location
Burlington, MA
Fiscal year end
30 June
Latest financial report
10-Q - Q4 2025 - 17 Feb 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 515% %
Debt-to-equity 41% %
Return On Equity -26% % 47%
Return On Assets -18% %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 5,390,895 shares 207%
Common Stock, Shares, Outstanding 5,377,329 shares 230%
Entity Public Float $5,213,998 USD -61%
Common Stock, Value, Issued $54 USD 238%
Weighted Average Number of Shares Outstanding, Basic 4,536,235 shares 188%
Weighted Average Number of Shares Outstanding, Diluted 4,536,235 shares 188%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $15,000,000 USD
Research and Development Expense $9,850,527 USD 24%
General and Administrative Expense $7,471,389 USD -5.1%
Operating Income (Loss) $3,571,355 USD 76%
Nonoperating Income (Expense) $2,509,928 USD -137%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $6,081,283 USD 27%
Income Tax Expense (Benefit) $417,375 USD -202%
Net Income (Loss) Attributable to Parent $5,694,276 USD 31%
Earnings Per Share, Basic -2.38 USD/shares 84%
Earnings Per Share, Diluted -3 USD/shares 81%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $22,170,414 USD 410%
Accounts Receivable, after Allowance for Credit Loss, Current $1,109,908 USD 3021%
Assets, Current $23,386,923 USD 432%
Property, Plant and Equipment, Net $2,573 USD 31%
Operating Lease, Right-of-Use Asset $75,219 USD -62%
Intangible Assets, Net (Excluding Goodwill) $4,473,426 USD -13%
Goodwill $8,737,953 USD 3.9%
Assets $36,598,302 USD 101%
Accounts Payable, Current $520,709 USD -66%
Liabilities, Current $2,586,308 USD 21%
Deferred Income Tax Liabilities, Net $425,527 USD -50%
Operating Lease, Liability, Noncurrent $19,322 USD
Other Liabilities, Noncurrent $3,647 USD
Liabilities $6,897,478 USD 56%
Accumulated Other Comprehensive Income (Loss), Net of Tax $2,225,265 USD 40%
Retained Earnings (Accumulated Deficit) $186,389,115 USD -3.1%
Stockholders' Equity Attributable to Parent $29,700,824 USD 116%
Liabilities and Equity $36,598,302 USD 101%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $3,794,648 USD 14%
Net Cash Provided by (Used in) Financing Activities $3,253,615 USD
Common Stock, Shares Authorized 30,000,000 shares 0%
Common Stock, Shares, Issued 5,377,329 shares 230%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $560,488 USD 88%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $22,250,061 USD 404%
Deferred Tax Assets, Valuation Allowance $26,139,160 USD -5.6%
Deferred Tax Assets, Gross $26,956,776 USD -5%
Operating Lease, Liability $0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $4,172,526 USD 55%
Lessee, Operating Lease, Liability, to be Paid $145,275 USD
Property, Plant and Equipment, Gross $47,716 USD -0.09%
Operating Lease, Liability, Current $85,210 USD -34%
Lessee, Operating Lease, Liability, to be Paid, Year Two $182,854 USD
Lessee, Operating Lease, Liability, to be Paid, Year One $119,593 USD -38%
Operating Lease, Weighted Average Discount Rate, Percent 0.035 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $2,457 USD -98%
Preferred Stock, Shares Authorized 3,000,000 shares 0%
Additional Paid in Capital $218,315,150 USD 10%
Deferred Tax Assets, Net of Valuation Allowance $26,100,000 USD -5.8%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%